4 months After Eli Lilly’s 7% Slump On Its Guidance Cut, What’s Left To Like? A Lot, Says One Analyst. Investor's Business Daily

There’s still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.
The post After Eli Lilly's 7% Slump On Its Guidance Cut, What's Left To Like? A Lot, Says One Analyst. appear…